+499.5%
MRNA vs NUE
+82.6%
+416.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NUE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.5% | -1.7% | -2.6% |
| 7D | +5.5% | +4.2% | +1.3% | +8.9% |
| 30D | +158.7% | -5.0% | +163.7% | +163.4% |
| 3M | +182.1% | -0.2% | +182.3% | +187.2% |
| 6M | +151.8% | +49.1% | +102.7% | +111.6% |
| YTD | +393.6% | +61.0% | +332.6% | +300.6% |
| 1Y | +499.5% | +82.5% | +416.9% | +362.7% |
| All | +499.5% | +82.6% | +416.9% | +362.7% |
Cumulative growth
Daily Returns
Daily percentage return beside NUE.
Daily Out/Under-Performance
Portfolio return minus NUE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NUE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NUE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling